Pharmacokinetics of primaquine and carboxyprimaquine in korean patients with vivax malaria (original) (raw)
References
Anonymous., Epidemiology of malaria in Korea, 2000. CDMR., 12, 5–10 (2001). Google Scholar
Bangchang, K. N., Karbwang, J., and Back, D. J., Primaquine metabolism by human liver microsomes; effect of other antimalarial drugs.Biochem. Pharmacol., 44, 587–590 (1992). ArticlePubMedCAS Google Scholar
Bhatia, S. C., Saraph, Y. S., Revankar, S. N., Doshi, K. J., Bharucha, E. D., Desai, N. D., Vaidya, A. B., Subramanyam, D., Gupta, K. C., and Satoskar, R. S., Pharmacokinetics of primaquine in patients with P. vivax malaria.Eur. J. Clin. Pharm., 31, 205–210 (1986). ArticleCAS Google Scholar
Bunnag, D., Karbwang, J., Thanvibul, A., Chittamas, S., Ratanapongse, Y., Chalermrut, K., Bangchang, K. N., and Harinasuta, T., High dose of primaquine in primaquine resistant vivax malaria.Trans. R. Soc. Trop. Med. Hyg., 88, 218–219 (1994). ArticlePubMedCAS Google Scholar
Chai, I. H., Lim, G. I., Yoon, S. N., Oh, W. I., Kim, S. J., and Chai, J. Y., Occurrence of tertian malaria in a male patient who has never been abroad.Kor. J. Parasitol., 32, 195–200 (1994). ArticleCAS Google Scholar
Clyde, D. F. and McCarthy, V. C., Radical cure of Chesson strain vivax malaria in man by 7, not 14, days of treatment with primaquine.Am. J. Trop. Med. Hyg., 26, 562–563 (1977). PubMedCAS Google Scholar
Colin, D., Primaquine. In Colin, D., Boobis, A. R., Burley, D., Davies, D. M., Davies., D. S., Harrison, P. I., Orme, M. L., Park, B. K., and Goldberg, L. I. (Eds.). Therapeutic Drug. Edinbergh: Churchill Livingston, New York, pp.209–212, (1991). Google Scholar
Constantino, L., Paixao, P., Moreira, R., Portela, M. J., Do Rosario, V. E., and Iley, J., Metabolism of primaquine by liver homogenate fractions. Evidence for monoamine oxidase and cytochrome P450 involvement in the oxidative deamination of primaquine to carboxyprimaquine.Exp. Toxicol. Pathol., 51, 299–303 (1999). PubMedCAS Google Scholar
Dua, V. K., Kar, P. K., Sarin, R., and Sharma, V. P., High-performance liquid chromatographic determination of primaquine and carboxyprimaquine concentrations in plasma and blood cells in Plasmodium vivax malaria cases following chronic dosage with primaquine.J. Chromatogr. B., 675, 93–98 (1996). ArticleCAS Google Scholar
Endoh, Y. S., Yoshimura, H., Sasaki, N., Ishihara, Y., Sasaki, H., Nakamura, S., Inoue, Y., and Nishikawa, M., High-performance liquid chromatographic determination of pamaquine, primaquine and carboxyprimaquine in calf plasma using electrochemical detection.J. Chromatogr., 592, 123–129 (1992). Google Scholar
Fletcher, K. A., Evans, D. A., Gilles, H. M., Greaves, J., Bunnag, D., and Harinasuta, T., Studies on the pharmacokinetics of primaquine.Bull. World Health Organ., 59, 407–412 (1981). PubMedCAS Google Scholar
Gashaw, I., Kirchheiner, J., Goldammer, M., Bauer, S., Seidemann, J., Zoller, K., Mrozikiewicz, P. M., Roots, I., and Brockmoller, J., Cytochrome P450 3A4 messenger ribonucleic acid induction by rifampin in human peripheral blood mononuclear cells: correlation with alprazolam pharmacokinetics.Clin. Pharmacol. Ther., 774, 448–457 (2003). Google Scholar
Greaves, J., Evans, D. A., Gilles, H. M., Fletcher, K. A., Bunnag, D., and Harinasuta, T., Plasma kinetics and urinary excretion of primaquine in man.Brit. J. Clin. Pharmacol., 10, 399–405 (1980). CAS Google Scholar
Kennedy, E. and Frischer, H., Distribution of primaquine in human blood: drug-binding to α1-glycoprotein.J. Lab. Clin. Med., 116, 871–878 (1990). PubMedCAS Google Scholar
Kim, J. H., Park, K. S., Lee, J. M., Choi, J. H., Lee, I. S., Kim, M. Y., Kim, Y. R., and Kang, M. W., A case of primaquine-resistant tertian malaria.Kor. J. Infect. Dis., 29, 503–507 (1997). Google Scholar
Kimura, M., Tomizawa, I., Takizwa, Y., and Ohtomo, H., A study of relapsed cases of vivax malaria after the standard primaquine therapy.Kansenshogaku Zasshi., 70, 1086–1091 (1996). PubMedCAS Google Scholar
Law, M. Y., Slawson, M. H., and Moody, D. E., Selective involvemnet of cytochrome P450 2D subfamily in_in vivo_ 4-hydroxylation of amphetamine in rat.Drug Metab. Dispos., 28, 348–353 (2000). PubMedCAS Google Scholar
McEvoy, G. K., Primaquine phosphate. In McEvoy, G. K., Miller, J. L., Snow. E. K., and Welsh. O. H. (Eds.). AHFS Drug information. ASHP Inc., Bethesda, pp.754–756, (2002). Google Scholar
Mihaly, G. W., Nicholl, D. D., Ward, S. A., Edwards, G., Orme, M. L., and Breckenridge, A. M., Pharmacokinetics of prmaquine in man: Identification of the carboxylic acid derivative as a major plasma metabolite.Brit. J. Clin. Pharmacol., 17, 441–446 (1984). CAS Google Scholar
Mihaly, G. W., Ward, S. A., Edwards, G., Nicholl, D. D., Orme, M. L., and Breckenridge, A. M., Pharmacokinetics of primaquine in man. I. Studies of the absolute bioavailability and effects of dose size.Brit. J. Clin. Pharmacol., 19, 745–750 (1985). CAS Google Scholar
Pukrittayakamee, S., Vanijanonta, S., Chantra, A., Clemens, R., and White, N. J., Blood stage antimalarial efficacy of primaquine in Plasmodium vivax malaria.J. Infect. Dis., 169, 932–935 (1994). PubMedCAS Google Scholar
Rieckmann, K. H., Yeo, A. E., Davis, D. R., Hutton, D. C., Wheatley, P. F., and Simpson, R., Recent military experience with malaria chemoprophylaxis.Med. J. Aust., 158, 446–449 (1993). PubMedCAS Google Scholar
Ward, S. A., Mihaly, G. W., Edwards, G., Looareesuwin, S., Phillips, R. E., Chanthavanich, P., Warrell, D. A., Orme, M. L., and Breckenridge, A. M., Pharmacokinetics of primaquine in Man. II. Comparison of acute vs chronic dosage in Thai subjects.Br. J. Clin. Pharmacol., 19, 751–755 (1985). PubMedCAS Google Scholar
Zhao, X. J. and Ishizaki, T., A further interaction study of quinine with clinically important drugs by human liver microsomes: determinations of inhibition constant (Ki) and type of inhibition.Eur. J. Drug Metab. Pharmacokinet., 24, 272–278 (1999). PubMedCAS Google Scholar